Skip to main content

Table 3 Survival time

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

1-year survival rate

3-year survival rate

5-year survival rate

mOS

mOS after metastasis

N

%

N

%

N

%

17

62.96

6

22.22

4

14.81

22.0 (95% CI 10.789–33.211)

23.0 (95% CI 16.443–29.557)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us